Study 20170703 is a phase 4, randomized, double-blind, parallel-group, placebo-controlled study to evaluate the efficacy and safety of erenumab against...
AMG 334 20160172 Pediatric Migraine PK Study.
This study will evaluate the efficacy and safety of erenumab in migraine prevention in children (6 to <12 years) and...
To evaluate the effect of erenumab compared to placebo on disability in employed subjects with episodic migraine (EM) who have...
The purpose of this study is to evaluate the efficacy and safety of erenumab in patients with chronic migraine in...
The main purpose of this study is to evaulate the efficacy and safety of galcanezumab in participants 6 to 17...
English (USA)